Page 3 - Applied Testing News Today

Partnership to leverage the Helix Laboratory Platform powered by QIAGEN's biopharma relationships, NGS capabilities, and global regulatory expertise Addressing health burden in neuro-degenerative

therascreenKRAS RGQ PCR kit approved as a companion diagnostic to aid in identifying non-small cell lung cancer (NSCLC) patients eligible for treatment with KRAZATI (adagrasib) KRAS mutations

NeuMoDx MPXV Test Strip enables researchers to quickly identify both clade I II of the monkeypox virus Dual-target design to reduce false negatives Multiplex test strengthens QIAGEN's

Initial development and validation of clinical trial assay Next-generation sequencing (NGS) based assay targeting LRRK2 from blood samples Collaboration expands QIAGEN's NGS testing

U.S. public health agency validated digital PCR technologies including QIAcuity as the way to reliably detect multiple disease targets in wastewater samples QIAcuity previously awarded U.S.

Dr. Eva Pisa proposed as a new member to the Supervisory Board, contributes significant leadership experience in Life Science and Molecular Diagnostics industry All seven current Supervisory

BLIRT adds new R&D and manufacturing capabilities for customized and standardized recombinant enzymes, as well as molecular biology reagents Strengthens QIAGEN's sample technologies business

Element Biosciences, Inc., developer of a new and disruptive DNA sequencing platform, today announced a partnership with QIAGEN to validate its leading NGS library prep and target enrichment offerings

QuantiFERON-TB Gold Plus (QFT-Plus), the fourth generation of the modern gold standard for TB detection, receives Chinese NMPA approval as test for ac

Press release content from Business Wire. The AP news staff was not involved in its creation.